Patent: Pharmaceuticals & Biotechnology

Members of our patent practice group at Steptoe & Johnson LLP have helped build biotechnology and pharmaceutical patent portfolios through identifying and protecting intellectual property assets, performing intellectual property due diligence of acquisition targets, advancing and managing new discoveries, developing legal infrastructure, and expanding and protecting US and other commercial interests.

Our attorneys have also been involved in strategic counseling and litigation activities assembling and asserting patent rights in Hatch-Waxman litigation. Our extensive experience in the life sciences arena includes pharmaceuticals, medical devices, and biotechnology. Our group works on a variety of life-sciences projects including: 

• Small molecules
• Pharmaceutical compositions
• Drug discovery
• Drug delivery
• Structural biology
• Conjugates
• Combinatorial chemistry
• Stem cells
• Membrane technology
• Enzymes
• Biosynthesis
• Bioinformatics
• Cheminformatics
• Recombinant DNA technology
• RNA
• Gene therapy
• Transgenic animals
• Transgenic plants
• Cloning vectors
• Vaccines
• Viruses
• Oncogenes
• Disease treatment and prevention
• Nutritional supplements
• Wound dressings
• Skin care products
• Ostomy products
• Surgical instruments
• Stents
• Catheters
• Medical electrodes
• Imaging technologies, including ultrasound, MRI, and near-IR imaging

Publications & Speaking Engagements

• Court Voids US EPA Ban on Use of Third-Party Human Test Data
  Environmental & Chemical Regulatory Update
  June 2003